Multiple ventricular septal defects: a new strategy

Antonio F Corno1, Pramod R Kandakure2, Ramana Rao V Dhannapuneni2

  • 1King Fahad Medical City Riyadh, Saudi Arabia.

Frontiers in Pediatrics
|January 9, 2014
PubMed

Insights

This study introduces a new strategy using an adjustable Pulmonary Artery Banding (PAB) device for infants with multiple Ventricular Septal Defects (VSDs). The approach resulted in 0% mortality and facilitated spontaneous closure of VSDs, simplifying management.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery

Background:

  • Multiple Ventricular Septal Defects (VSDs) present complex management challenges in infants.
  • A novel strategy involving adjustable Pulmonary Artery Banding (PAB) was evaluated.

Purpose of the Study:

  • To assess the efficacy and safety of a new strategy for managing multiple VSDs in infants.
  • To evaluate the use of an adjustable device for Pulmonary Artery Banding (PAB).

Main Methods:

  • A prospective, multicenter study included 17 infants with multiple VSDs undergoing PAB with an adjustable FloWatch-PAB device.
  • Patients had various associated cardiac anomalies and some required mechanical ventilation.
  • Follow-up averaged 48 months, with adjustments to the PAB device as needed.

Main Results:

  • No early or late deaths were observed.
  • All patients required FloWatch-PAB adjustments to manage pulmonary artery pressure.
  • 59% of patients underwent re-operation for PAB removal and VSD closure; 88% showed spontaneous closure of muscular VSDs.

Conclusions:

  • The adjustable PAB strategy simplifies management of multiple VSDs in infants, achieving 0% mortality.
  • This approach facilitates delayed surgical closure of residual VSDs at a higher body weight.
  • The strategy may be sufficient as the sole intervention for certain types of multiple VSDs.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422